Bionano Genomics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	-232.49	-132.6	-72.44	-41.11	-29.82	-18.5	-23.37	-18.85
Depreciation & Amortization	13.97	10.32	4.04	1.48	1.13	1.32	1.5	1.12
Share-Based Compensation	15.18	22.42	9.72	1.55	1.35	1.19	0.38	0.13
Other Operating Activities	78.17	-24.96	-13.25	-0.24	-2.19	-3.96	0.66	-5.89
Operating Cash Flow	-125.18	-124.82	-71.93	-38.31	-29.53	-19.94	-20.82	-23.5
Capital Expenditures	-1.69	-3.17	-2.07	0	-0.06	-0.33	-1.02	-1.35
Acquisitions	0.1	-30.65	-49.09	-2.45	0	0	0	0
Change in Investments	25.75	116.69	-226.91	0	0	0	0	0
Other Investing Activities	-	-0.1	-	-	-	-	-	-
Investing Cash Flow	24.16	82.77	-278.06	-2.45	-0.06	-0.33	-1.02	-1.35
Share Issuance / Repurchase	56.38	23.04	351.12	66.63	20.56	19.39	0.01	0
Debt Issued / Paid	66.43	-0.04	-15.01	-4.72	9.82	16.38	0	1.89
Other Financing Activities	-9	-	-	-	-	-	17.59	23.54
Financing Cash Flow	113.82	23.01	336.11	61.9	30.38	35.78	17.61	25.43
Exchange Rate Effect	0.07	-0.04	0	0	0	0	0	0
Net Cash Flow	12.86	-19.08	-13.88	21.14	0.79	15.5	-4.23	0.58
Free Cash Flow	-126.87	-127.99	-73.99	-38.31	-29.59	-20.28	-21.84	-24.85
Free Cash Flow Margin	-351.29%	-460.36%	-411.51%	-450.59%	-292.12%	-168.95%	-229.73%	-365.77%
Free Cash Flow Per Share	-3.71	-4.43	-2.67	-3.67	-19.76	-28.65	-80.84	-108.70

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).